• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Submit An Op-Ed

HIT Consultant contributors are thought-leaders in the healthcare technology community who bring deep insight and knowledge to our content and platform.

If you are interested in submitting an op-ed for publication, please see the guidelines below. 

Submit to: submissions@hitconsultant.net.

You can also find examples of our op-eds in our opinion section. 

Submitting Op-Ed Guidelines

– All op-eds submitted for publication at HIT Consultant should be the guest author’s original work content should not be published anywhere else.

– Op-eds should be between 750– 1,500 words. Longer posts will be accepted pending content relevance.

– Op-eds should be healthcare technology-related. 

– HIT Consultant does not accept self-promotional articles or advertorials. These types of works will automatically be rejected. Please refrain from mentioning your company or products in the post. Contributed articles are for the purpose of showcasing thought leadership within the industry. Company mentions will either result in a rejection or being removed from the submission before publication.

– Please include a short 1 to 2-line author bio and company profile. This includes title and any social media profiles. Include a headshot for image next to byline.
Include any high-resolution images/graphs/figures that support the article.

– Please cite sources used and provide proper attribution especially when citing statistics and quotes.

– Articles should be reviewed for clarity, spelling, punctuation and grammar prior to submission.

– All op-eds will be reviewed by HIT Consultant staff prior to publication.

– HIT Consultant reserves the right to revise any contributed content to meet the needs of the readers.

– All contributed articles are promoted via HIT Consultant social media outlets.

PLEASE NOTE: HIT Consultant cannot respond to every submission sent in. If your article is considered for publication, a member of the editorial staff will follow up with a publication date. 

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |